[
  {
    "id": 1,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT04904588",
    "brief_title": "HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide",
    "phase": "I",
    "disease_names_lead": "Lymphoma, Acute Leukemia, Myelodysplastic Syndrome",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": true,
    "biomarker_inc_matches": null,
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Industrial"
  },
  {
    "id": 2,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT04872595",
    "brief_title": "Personalized r-ATG for the Improvement of Survival through Enhanced Immune Reconstitution in Patients with Acute Leukemia or Myelodysplastic Syndrome Undergoing Ex-Vivo CD34-Selected Allogeneic-HCT, (PRAISE-IR)",
    "phase": "II",
    "disease_names_lead": "Myelodysplastic Syndrome, Acute Myeloid Leukemia (AML)",
    "lead_disease_matches": "Y",
    "disease_names": "Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia (ALL).",
    "disease_matches": "Y",
    "biomarker_exc_matches": false,
    "biomarker_inc_matches": null,
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "National"
  },
  {
    "id": 3,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT04905588",
    "brief_title": "Inotuzumab Ozogamicin in Treating Younger Patients with B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia",
    "phase": "III",
    "disease_names_lead": "B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": null,
    "biomarker_inc_matches": true,
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Externally Peer Reviewed"
  },
  {
    "id": 4,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT04904588",
    "brief_title": "Imatinib Mesylate and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia",
    "phase": "IV",
    "disease_names_lead": "Lymphoma, Acute Leukemia, Myelodysplastic Syndrome",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": null,
    "biomarker_inc_matches": false,
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Externally Peer Reviewed"
  },
  {
    "id": 5,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT04704588",
    "brief_title": "Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults with Newly Diagnosed B Acute Lymphoblastic Leukemia",
    "phase": "II",
    "disease_names_lead": "Acute Lymphoblastic Leukemia (ALL)",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": "biomarker_exc_matches",
    "biomarker_inc_matches": "biomarker_inc_matches",
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Institutional"
  },
  {
    "id": 6,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT02904588",
    "brief_title": "Venetoclax and Vincristine Liposomal in Treating Patients with Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia",
    "phase": "II",
    "disease_names_lead": "Refractory B Acute Lymphoblastic Leukemia",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": "biomarker_exc_matches",
    "biomarker_inc_matches": "biomarker_inc_matches",
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Industrial"
  },
  {
    "id": 7,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT09904588",
    "brief_title": "Inotuzumab Ozogamicin and Blinatumomab in Treating Patients with Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage_matches Acute Lymphoblastic Leukemia",
    "phase": "II",
    "disease_names_lead": "Refractory B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": "biomarker_exc_matches",
    "biomarker_inc_matches": "biomarker_inc_matches",
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Industrial"
  },
  {
    "id": 8,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT04909588",
    "brief_title": "A Study to Investigate Blinatumomab in Combination with Chemotherapy in Patients with Newly Diagnosed B-Lymphoblastic Leukemia",
    "phase": "II",
    "disease_names_lead": "B Acute Lymphoblastic Leukemia",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": "biomarker_exc_matches",
    "biomarker_inc_matches": "biomarker_inc_matches",
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Industrial"
  },
  {
    "id": 9,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT04994588",
    "brief_title": "Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients with High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy",
    "phase": "II",
    "disease_names_lead": "B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": "biomarker_exc_matches",
    "biomarker_inc_matches": "biomarker_inc_matches",
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Industrial"
  },
  {
    "id": 10,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT04909588",
    "brief_title": "Study to Test AKR1C3-Activated Prodrug OBI-3424 (OBI-3424) in Patients with Relapsed / Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)",
    "phase": "II",
    "disease_names_lead": "B Acute Lymphoblastic Leukemia",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": "biomarker_exc_matches",
    "biomarker_inc_matches": "biomarker_inc_matches",
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Industrial"
  },
  {
    "id": 11,
    "hide": "hide",
    "star": "",
    "nct_id": "NCT04904587",
    "brief_title": "Testing the Use of Steroids and Tyrosine Kinase Inhibitors with Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults",
    "phase": "II",
    "disease_names_lead": "B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1",
    "lead_disease_matches": "Y",
    "disease_names": "Recurrent Chronic Lymphocytic Leukemia (CLL), Acute Leukemia.",
    "disease_matches": "Y",
    "biomarker_exc_matches": "biomarker_exc_matches",
    "biomarker_inc_matches": "biomarker_inc_matches",
    "hiv_exc_matches": "hiv_exc_matches",
    "brain_mets": "brain_mets",
    "pt_inc_matches": "pt_inc_matches",
    "plt_matches": "plt_matches",
    "wbc_matches": "wbc_matches",
    "perf_matches": "perf_matches",
    "gender_matches": "Y",
    "age_matches": "age_matches",
    "va_matches": "va",
    "nih_cc_matches": "nih_cc",
    "study_source": "Industrial"
  }
]